Catalyst Wire Dossier Catalyst Wire Dossier

Tenalisib

tenalisib · Rhizen Pharmaceuticals SA
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Tenalisib, covering 2021-07-22 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC) [Phase 2]

See pricing